Table 1 Baseline characteristics.
SOM palsy | Control subjects | P value | |
|---|---|---|---|
Number of patients, n (%) | 60 (50.0) | 60 (50.0) | |
Male, n (%) | 37 (62) | 36 (60) | 0.854 |
Age (years; median, IQR) | 12 (6–42) | 12 (5–43) | 0.286 |
Patients with SOM palsy | |||
Right eye palsy | 30 (50.0) | NA | |
Horizontal deviation at distance fixation* | 2 (0–8) | NA | |
Horizontal deviation at near fixation* | 6 (0–11) | NA | |
Vertical deviation at distance fixation* | 10 (5–18) | NA | |
Vertical deviation at near fixation* | 12 (6–20) | NA | |
Controls, rationale for MRI | |||
Epilepsy, seizure | NA | 12 (20.0) | |
Tumoral lesion (benign or malignant) | NA | 11 (18.3) | |
Neurological disorder (cognitive impairment, developmental delay) | NA | 11 (18.3) | |
Reduced visual acuity (suspected optic neuropathy) | NA | 11 (18.3) | |
Vascular evaluation (stroke, veinous thrombosis) | NA | 7 (11.8) | |
Sinonasal evaluation | NA | 3 (5.0) | |
Other (head trauma, encephalitis) | NA | 5 (8.3) |
